{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T11:11:31Z","timestamp":1792149091916,"version":"4.4.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"13-14","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,9,3]],"date-time":"2011-09-03T00:00:00Z","timestamp":1315008000000},"content-version":"vor","delay-in-days":367,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008353","name":"Funda\u00e7\u00e3o de Apoio ao Ensino, Pesquisa e Assist\u00eancia do Hospital das Cl\u00ednicas da Faculdade de Medicina de Ribeir\u00e3o Preto da Universidade de S\u00e3o Paulo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008353","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.lfs.2010.08.009","type":"journal-article","created":{"date-parts":[[2010,9,4]],"date-time":"2010-09-04T06:45:10Z","timestamp":1283582710000},"page":"445-450","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Pindolol potentiates the panicolytic effect of paroxetine in the elevated T-maze"],"prefix":"10.1016","volume":"87","author":[{"given":"V\u00e2nia R.","family":"Sela","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila M.","family":"Roncon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"H\u00e9lio","family":"Zangrossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederico G.","family":"Graeff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth A.","family":"Audi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2010.08.009_bb0005","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1001\/archpsyc.1994.03950030084009","article-title":"Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors","volume":"51","author":"Artigas","year":"1994","journal-title":"Archieves of General Psychiatry"},{"key":"10.1016\/j.lfs.2010.08.009_bb0010","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2174\/138945006775515446","article-title":"Pindolol augmentation of antidepressant response","volume":"7","author":"Artigas","year":"2006","journal-title":"Current Drug Targets"},{"key":"10.1016\/j.lfs.2010.08.009_bb0015","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1043-6618(03)00097-5","article-title":"Effects of Hypericum perforatum and paroxetine on rat performance in the elevated T-maze","volume":"48","author":"Beijamini","year":"2003","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.lfs.2010.08.009_bb0020","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1176\/ajp.154.1.37","article-title":"Effect of pindolol in hastening response to fluoxetine in the treatment of major depression: a doubleblind, placebo-controlled trial","volume":"154","author":"Berman","year":"1997","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.lfs.2010.08.009_bb0025","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.brainres.2005.08.006","article-title":"Involvement of dorsolateral periaqueductal gray cholecystokinin-2 receptors in the regulation of a panic-related behavior in rats","volume":"1059","author":"Bertoglio","year":"2005","journal-title":"Brain Research"},{"key":"10.1016\/j.lfs.2010.08.009_bb0030","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/00004714-199506000-00011","article-title":"Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression","volume":"15","author":"Blier","year":"1995","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.lfs.2010.08.009_bb0035","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/sj.npp.1395360","article-title":"Serotonin and drug-induced therapeutic responses in major depression, obsessive\u2013compulsive and panic disorders","volume":"21","author":"Blier","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.lfs.2010.08.009_bb0040","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0006-3223(02)01643-8","article-title":"Is there a role for 5-HT1A agonists in the treatment of depression?","volume":"53","author":"Blier","year":"2003","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.lfs.2010.08.009_bb0045","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1176\/ajp.155.10.1346","article-title":"Effect of pindolol on onset of action of paroxetine in the treatment of major depression: intermediate analysis of a double-blind, placebo-controlled trial","volume":"155","author":"Bordet","year":"1998","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.lfs.2010.08.009_bb0050","first-page":"338","article-title":"Interest of the use of pindolol in the treatment of depression: review","volume":"29","author":"Brousse","year":"2003","journal-title":"L'Enc\u00e9phale"},{"key":"10.1016\/j.lfs.2010.08.009_bb0055","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0014-2999(98)00402-6","article-title":"Combining pindolol and paroxetine in an animal model of chronic antidepressant action-can early onset of action be detected?","volume":"352","author":"Cryan","year":"1998","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.lfs.2010.08.009_bb0060","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/0028-3908(84)90095-9","article-title":"Eletrophysiologically identified serotonin receptors in the rat CNS: effect of antidepressant treatment","volume":"23","author":"De Montigny","year":"1984","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.lfs.2010.08.009_bb0065","article-title":"Pindolol boosts or blocks fluoxetine in the rat forced swimming test_FST depending on the fluoxetine dose","volume":"22","author":"Detke","year":"1996","journal-title":"Society for Neuroscience Abstracts"},{"key":"10.1016\/j.lfs.2010.08.009_bb0070","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1038\/sj.bjp.0703496","article-title":"Latency to paroxetine-induced anxiolysis in the rat is reduced by co-administration of the 5-HT1A receptor antagonist Way100635","volume":"130","author":"Duxon","year":"2000","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.lfs.2010.08.009_bb0075","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.neubiorev.2008.05.017","article-title":"Neurobiology of panic disorder: from animal models to brain neuroimaging","volume":"32","author":"Graeff","year":"2008","journal-title":"Neuroscience and Biobehavioral Reviews"},{"key":"10.1016\/j.lfs.2010.08.009_bb0080","series-title":"Textbook of Biological Psychiatry","first-page":"879","article-title":"Animal models of anxiety disorders","author":"Graeff","year":"2002"},{"key":"10.1016\/j.lfs.2010.08.009_bb0085","first-page":"67","article-title":"The elevated T maze, a new experimental model of anxiety and memory: effect of diazepam","volume":"26","author":"Graeff","year":"1993","journal-title":"Brazilian Journal of Medical and Biological Research"},{"key":"10.1016\/j.lfs.2010.08.009_bb0090","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0149-7634(98)00024-4","article-title":"The elevated T-maze as an experimental model of anxiety","volume":"23","author":"Graeff","year":"1998","journal-title":"Neuroscience and Biobehavioral Reviews"},{"key":"10.1016\/j.lfs.2010.08.009_bb0095","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0014-2999(97)01552-5","article-title":"Effect of the reversible monoamine oxidase-A inhibitor befloxatone on the rat 5-hydroxytryptamine neurotransmission","volume":"343","author":"Haddjeri","year":"1998","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.lfs.2010.08.009_bb0100","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0091-3057(97)00008-7","article-title":"Effects of the co-administration of 5-HT1A receptor antagonists with an SSRI in conditioned fear stress-induced freezing behavior","volume":"58","author":"Hashimoto","year":"1997","journal-title":"Pharmacology, Biochemistry and Behavior"},{"key":"10.1016\/j.lfs.2010.08.009_bb0105","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/00004714-200010000-00011","article-title":"Pindolol augmentation in patients with treatment-resistant panic disorder: a double-blind, placebo-controlled trial","volume":"20","author":"Hirschmann","year":"2000","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.lfs.2010.08.009_bb0110","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neuropharm.2006.03.009","article-title":"Prediction of anti-panic properties of escitalopram in the dorsal periaqueductal grey model of panic anxiety","volume":"51","author":"Hogg","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.lfs.2010.08.009_bb0115","article-title":"Augmentation of the antidepressant action of SSRIs by pindolol may not be explained by 5-HT1A receptor antagonism","volume":"22","author":"Jackson","year":"1996","journal-title":"Society for Neuroscience Abstracts"},{"key":"10.1016\/j.lfs.2010.08.009_bb0120","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1440-1819.2006.01512.x","article-title":"Comparison of venlafaxine extended release versus paroxetine for treatment of patients with generalized anxiety disorder","volume":"60","author":"Kim","year":"2006","journal-title":"Psychiatry and Clinical Neurosciences"},{"key":"10.1016\/j.lfs.2010.08.009_bb0125","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/j.1440-1819.2008.01862.x","article-title":"Clinical evaluation of paroxetine in post-traumatic stress disorder (PTSD): 52-week, non-comparative open-label study for clinical use experience","volume":"62","author":"Kim","year":"2008","journal-title":"Psychiatry and Clinical Neurosciences"},{"key":"10.1016\/j.lfs.2010.08.009_bb0130","doi-asserted-by":"crossref","first-page":"222","DOI":"10.4088\/JCP.v65n0213","article-title":"Controlled-release paroxetine in the treatment of patients with social anxiety disorder","volume":"65","author":"Lepola","year":"2004","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.lfs.2010.08.009_bb0135","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S0091-3057(97)00057-9","article-title":"Role of 5-HT 2A and 5-HT2C receptors subtypes in the two types of fear generated by the elevated T maze","volume":"58","author":"Mora","year":"1997","journal-title":"Pharmacology, Biochemistry and Behavior"},{"key":"10.1016\/j.lfs.2010.08.009_bb0140","doi-asserted-by":"crossref","first-page":"437","DOI":"10.4088\/JCP.v58n1005","article-title":"Pindolol augmentation of treatment-resistant depressed patients","volume":"58","author":"Moreno","year":"1997","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.lfs.2010.08.009_bb0145","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0014-2999(99)00202-2","article-title":"5-HT1A receptor antagonists neither potentiate nor inhibit the effects of fluoxetine and befloxatone in the forced swim test in rats","volume":"372","author":"Moser","year":"1999","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.lfs.2010.08.009_bb0150","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ejphar.2008.01.040","article-title":"Effect of co-administration of the selective 5-HT1A receptor antagonist Way100635 and selective 5-HT1B\/1D receptor antagonist GR 127, 935 on anxiolytic effect of citalopram in conditioned fear stress in the rat","volume":"586","author":"Muraki","year":"2008","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.lfs.2010.08.009_bb0155","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0165-0270(85)90031-7","article-title":"Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat","volume":"14","author":"Pellow","year":"1985","journal-title":"Journal of Neuroscience Methods"},{"key":"10.1016\/j.lfs.2010.08.009_bb0160","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/S0140-6736(96)08007-5","article-title":"Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment","volume":"349","author":"Perez","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2010.08.009_bb0165","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1001\/archpsyc.56.4.375","article-title":"A double-blind, randomized, placebo-controlled trial of pindolol augmentation in depressive patients resistant to serotonin reuptake inhibitors","volume":"56","author":"Perez","year":"1999","journal-title":"Archieves of General Psychiatry"},{"key":"10.1016\/j.lfs.2010.08.009_bb0170","doi-asserted-by":"crossref","first-page":"238","DOI":"10.4088\/JCP.v65n0215","article-title":"Pindolol augmentation in depressed patients resistant to selective serotonin reuptake inhibitors: a double-blind, randomized, controlled trial","volume":"65","author":"Perry","year":"2004","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.lfs.2010.08.009_bb0175","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1590\/S0001-37652007000100010","article-title":"Elevated mazes as animal models of anxiety: effects of serotonergic agents","volume":"79","author":"Pinheiro","year":"2007","journal-title":"Anais da Academia Brasileira de Ci\u00eancias"},{"key":"10.1016\/j.lfs.2010.08.009_bb0180","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1177\/0269881107079866","article-title":"Anxiolytic and panicolytic effects of escitalopram in the elevated T-maze","volume":"22","author":"Pinheiro","year":"2008","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.lfs.2010.08.009_bb0185","first-page":"53","article-title":"Treatment of panic disorder: focus on paroxetine","volume":"37","author":"Pollack","year":"2003","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1016\/j.lfs.2010.08.009_bb0190","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0166-4328(03)00151-7","article-title":"Antipanic-like effect of serotonin reuptake inhibitors in the elevated T-maze","volume":"147","author":"Poltronieri","year":"2003","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/j.lfs.2010.08.009_bb0195","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0014-2999(96)00772-8","article-title":"The role of 5-HT1A and 5-HT1B receptors in antidepressant drug actions in the mouse forced swimming test","volume":"318","author":"Rebrobe","year":"1996","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.lfs.2010.08.009_bb0200","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1176\/appi.ajp.160.4.749","article-title":"Paroxetine treatment of generalized anxiety disorder: a double-blind, placebo-controlled study","volume":"160","author":"Rickels","year":"2003","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.lfs.2010.08.009_bb0205","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/hup.672","article-title":"Pindolol augmentation of selective serotonin reuptake inhibitors: accounting for the variability of results of placebo-controlled double-blind studies in patients with major depression","volume":"20","author":"Segrave","year":"2005","journal-title":"Human Psychopharmacology"},{"key":"10.1016\/j.lfs.2010.08.009_bb0210","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4088\/JCP.v66n0105","article-title":"Efficacy and tolerability of controlled-release paroxetine in the treatment of panic disorder","volume":"66","author":"Sheehan","year":"2005","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.lfs.2010.08.009_bb0215","first-page":"105","article-title":"The effects of pindolol addition to fluvoxamine and buspirone in chronic mild stress model of depression","volume":"7","author":"Sluzewska","year":"1996","journal-title":"Behavioral Pharmacology"},{"key":"10.1016\/j.lfs.2010.08.009_bb0220","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0165-0327(98)00221-3","article-title":"Mechanism of action of serotonin selective reuptake inhibitors. Serotonin receptors and pathways mediate therapeutic effects and side effects","volume":"51","author":"Stahl","year":"1998","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.lfs.2010.08.009_bb0225","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1176\/appi.ajp.158.10.1725","article-title":"Pindolol potentiation of paroxetine for generalized social phobia: a double-blind, placebo-controlled, crossover study","volume":"158","author":"Stein","year":"2001","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.lfs.2010.08.009_bb0230","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0091-3057(99)00261-0","article-title":"Behavioral effects of acute and chronic imipramine in the elevated T-maze model of anxiety","volume":"65","author":"Teixeira","year":"2000","journal-title":"Pharmacology, Biochemistry and Behavior"},{"key":"10.1016\/j.lfs.2010.08.009_bb0235","series-title":"Psychopharmacology: The Fourth Generation of Progress","first-page":"1081","article-title":"Treatment-resistant depression","author":"Thase","year":"1995"},{"key":"10.1016\/j.lfs.2010.08.009_bb0240","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.4088\/JCP.v65n1010","article-title":"Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder","volume":"65","author":"Trivedi","year":"2004","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.lfs.2010.08.009_bb0245","doi-asserted-by":"crossref","first-page":"S257","DOI":"10.1016\/S0924-977X(98)80466-5","article-title":"Pindolol does not augment the panicolytic effects of fluvoxamine in panic disorders patients","volume":"8","author":"Van Vliet","year":"1998","journal-title":"European Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.lfs.2010.08.009_bb0250","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00213-008-1420-4","article-title":"Running wheel activity is sensitive to acute treatment with selective inhibitors for either serotonin or norepinephrine reuptake","volume":"203","author":"Weber","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.lfs.2010.08.009_bb0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0361-9230(96)00381-4","article-title":"Behavioral validation of the elevated Tmaze, a new animal modelof anxiety","volume":"44","author":"Zangrossi","year":"1997","journal-title":"Brain Research Bulletin"},{"key":"10.1016\/j.lfs.2010.08.009_bb0260","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1016\/j.peptides.2004.06.016","article-title":"Systemic and intra-dorsal periaqueductal gray injections of cholecystokinin sulfated octapeptide (CCK-8s) induce a panic-like response in rats submitted to the elevated T-maze","volume":"25","author":"Zanoveli","year":"2004","journal-title":"Peptides"},{"key":"10.1016\/j.lfs.2010.08.009_bb0265","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/01.fbp.0000179280.05654.5a","article-title":"Chronic imipramine treatment sensitizes 5-HT1A and 5-HT2A receptors in the dorsal periaqueductal gray matter: evidence from the elevated T-maze test of anxiety","volume":"16","author":"Zanoveli","year":"2005","journal-title":"Behavioral Pharmacology"},{"key":"10.1016\/j.lfs.2010.08.009_bb0270","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/S0006-3223(00)00530-8","article-title":"Treatment with the presynaptic 5-HT1A-antagonist pindolol in patients with panic disorder","volume":"47","author":"Ziegenbein","year":"2000","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.lfs.2010.08.009_bb0275","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0924-9338(02)80705-2","article-title":"Pindolol in panic disorder","volume":"17","author":"Ziegenbein","year":"2002","journal-title":"European Psychiatry"},{"key":"10.1016\/j.lfs.2010.08.009_bb0280","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1016\/S0924-977X(98)80074-6","article-title":"Pindolol augmentation in treatment-resistant panic disorder and obsessive\u2013compulsive disorder","volume":"8","author":"Zohar","year":"1998","journal-title":"European Neuropsychopharmacology"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320510003723?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320510003723?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:09:05Z","timestamp":1758398945000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320510003723"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":56,"journal-issue":{"issue":"13-14","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S0024320510003723"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2010.08.009","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pindolol potentiates the panicolytic effect of paroxetine in the elevated T-maze","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2010.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}